Zacks Investment Management Purchases Shares of 43,270 American Healthcare REIT, Inc. (NYSE:AHR)

Zacks Investment Management purchased a new position in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 43,270 shares of the company's stock, valued at approximately $1,129,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kozak & Associates Inc. bought a new stake in American Healthcare REIT during the 3rd quarter valued at $28,000. Quarry LP bought a new stake in American Healthcare REIT during the 3rd quarter valued at $33,000. Tidemark LLC bought a new stake in American Healthcare REIT during the 3rd quarter valued at $44,000. Kessler Investment Group LLC bought a new stake in American Healthcare REIT during the 3rd quarter valued at $48,000. Finally, KBC Group NV bought a new stake in American Healthcare REIT during the 3rd quarter valued at $51,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Stock Down 1.2 %

AHR stock traded down $0.34 on Tuesday, hitting $27.86. 2,122,229 shares of the company's stock were exchanged, compared to its average volume of 1,523,640. American Healthcare REIT, Inc. has a 12-month low of $12.63 and a 12-month high of $29.99. The firm has a 50 day moving average price of $26.63 and a two-hundred day moving average price of $21.17. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. The stock has a market cap of $4.26 billion and a P/E ratio of -58.03.

American Healthcare REIT (NYSE:AHR - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. The business had revenue of $523.81 million for the quarter, compared to analysts' expectations of $474.26 million. The business's revenue for the quarter was up 12.8% on a year-over-year basis. As a group, equities research analysts expect that American Healthcare REIT, Inc. will post 1.42 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AHR has been the subject of a number of research analyst reports. KeyCorp lifted their target price on American Healthcare REIT from $16.00 to $27.00 and gave the company an "overweight" rating in a research report on Monday, September 16th. Morgan Stanley boosted their price target on American Healthcare REIT from $17.00 to $22.00 and gave the stock an "overweight" rating in a research report on Thursday, August 22nd. Royal Bank of Canada boosted their price target on American Healthcare REIT from $28.00 to $30.00 and gave the stock an "outperform" rating in a research report on Monday, November 18th. JMP Securities boosted their price target on American Healthcare REIT from $18.00 to $30.00 and gave the stock a "market outperform" rating in a research report on Friday, September 20th. Finally, Bank of America boosted their price target on American Healthcare REIT from $27.00 to $31.00 and gave the stock a "buy" rating in a research report on Tuesday, September 24th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $25.13.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.